Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Weight Loss 2Polyps 2Hyperplasia 2Stomach Neoplasms 1Psoriasis 1Osteoarthritis 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Megestrol Acetate 11Mirtazapine 5Olanzapine 4anamorelin 2Infliximab 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Gemcitabine 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1EOM613 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anorexia × Eicosapentaenoic Acid × Clear all
NCT00031707 2016-07-14

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Alliance for Clinical Trials in Oncology

Phase 3 Completed
429 enrolled

Anorexia, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡